Talk:USP General Chapter 71

Discussion page·2 threads·no archives

This is the discussion page for the article USP General Chapter 71. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Pore size is a conventionResolved

Good that the article says 0.45 μm is a compendial convention and retention is probabilistic. People treat filtration as an absolute barrier. — NewLabNell (talk) 09:45, 2 April 2026 (UTC)

It also explains why the chapter is framed as a test rather than as proof, which ties back to the statistical section on the main article. ✓ Done — EndotoxinEd (talk) 13:20, 2 April 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Reference to compounding chapter

The compounding chapter is cited but not discussed. Is that citation carrying its weight, or should it move to 503A compounding pharmacy? — Compounding_Cate (talk) 10:30, 7 June 2026 (UTC)

It is doing modest work here as the place a reader would go for sterile-preparation practice. I would keep it in further reading terms rather than expanding on it. — FiveOhThreeA (talk) 14:05, 7 June 2026 (UTC)

This page was last edited on 7 June 2026, by FiveOhThreeA. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).